ESTRO 36 Programme book and exhibition guide

tumor heterogeneity in the field of radiation oncology. One solution is the use of brachytherapy for the so-called ‘ dose-painting’. Because of the high dose gradients of brachytherapy dose distribution, separate areas can effectively be treated distinctly. Combination therapy approaches and focal therapies are thus key strategies to address this heterogeneity.

SATURDAY 6 MAY 2017

Chair: B. Pieters (The Netherlands) Co-chair: K. Kapp (Austria)

14:45 > Using heterogeneous brachytherapy dose distributions to target tumour cell heterogeneity R. Alonzi (UK) 15:03 > MRI assisted focal boost integrated with HDR monotherapy for low/ intermediate risk prostate cancer L. Dalimonte (Canada), J. Helou, G. Morton, H. Chung, M. McGuffin, A. Ravi, A. Loblaw 15:13 > The challenges of targeting tumour heterogeneity in the field of radiation oncology P. Lambin (The Netherlands) 15:31 > The impact of tumour heterogeneity on radiation therapy outcomes M. Gerlinger (UK) 15:49 > Hybrid F-MISO PET/MRI for radiation therapy response assessment in cervix cancer M. Daniel (Austria), P. Andrzejewski, A. Sturdza, K. Majercakova, P. Baltzer, K. Pinker, W. Wadsak, R. Pötter, T. Hellbich, P. Georg, D. Georg

SP-0101

OC-0102

SP-0103

SP-0104

OC-0105

SYMPOSIUM Innovations in ion beam therapy 14:45 - 16:00 | STRAUS 2-3 Chair: L.P. Muren (Denmark) Co-chair: M. Navratil (Czech Republic)

14:45 > Reducing range uncertainties: new approaches for stopping power determination and in-vivo range verification Speaker: K. Parodi (Germany) 15:10 > Mechanisms and Models of Particle Relative Biological Effectiveness (RBE) Speaker: D.J. Carlson (USA) 15:35 > New horizons in radiobiology: from Relative Biological Effectiveness to “new biology” Speaker: M. Durante (Italy)

SP-0106

SP-0107

SP-0108

SCIENTIFIC PROGRAMME | Programme and Exhibition Guide

88